ISLAMABAD - Finance Minister Muhammad Aurangzeb has announced a major relief for cancer patients in the federal budget, proposing the complete removal of customs duty on raw material used in the local production of cancer medicines. Presenting the budget in the National Assembly, the minister said the government is committed to making quality healthcare more affordable and accessible for the public.
National Tariff Policy 2025-30
Under the National Tariff Policy 2025-30, customs duty on more than 100 types of raw material used in the manufacturing of cancer and other life-saving medicines will be abolished. Aurangzeb said cancer places a heavy financial and emotional burden on patients and their families, making it essential for the government to take practical steps to reduce treatment costs.
Expected Impact on Medicine Prices
The move is expected to lower production costs for pharmaceutical companies, which could lead to a reduction in the prices of cancer medicines and other drugs used to treat serious diseases. The government believes that encouraging local manufacturing will reduce reliance on imports, strengthen the pharmaceutical sector and improve access to affordable treatment for patients across the country, he said.
US-supported masterclass equips 50 Pakistani entrepreneurs for global digital markets.
